Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin Secretion

NCT02397447 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Momordica charantia
DRUG: Placebo

Sponsor

University of Guadalajara